This session will provide insight into institutions’ and ORI’s responses to allegations of research misconduct in human research subjects, translational research, and animal research. Attendees will learn about the institutions’ and ORI’s requirements in response to allegations of research misconduct in accordance with the federal regulations, and what constitutes research misconduct versus unacceptable research practices.
ORI staff in attendance will be: - Sheila Garrity - Armineh Ghazarian - Dr. Yvette Carter - LaToya Lewis - Dr. Ranjini Ambalavanar - Alexandria Renfro
Learning Objectives:
Provide insight into the institutions' and ORI's implementation of the US Public Health Service regulations at 42 CFR Part 93, to address allegations of research misconduct
Discuss institutions’ and ORI’s work to ensure institutional compliance with the federal regulations
Share strategies and case studies to address procedural challenges at the institutional level, when investigating allegations of research misconduct related to research involving human subjects and/or animals